Athanasios Skarpelos - 25 May 2022 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Reporting relationship
Director
Issuer ticker
AVXL
Reported as of
25 May 2022
Net transaction value
-$407,000
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 May 2022, 20:30:22 UTC
Prior SEC filing
04 Aug 2021
Next SEC filing
29 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Athanasios Skarpelos

Key filing fact

Athanasios Skarpelos filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 27 May 2022.

Key facts

  • This page summarizes Athanasios Skarpelos's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 May 2022, 20:30.

Change

  • Previous filing in this sequence was filed on 04 Aug 2021.
  • Current net transaction value: -$407,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVXL transaction

Common Stock

Options Exercise

Transaction value
$46,000
Shares
+50,000
Change %
+3.8%
Price
$0.9200
Shares after
1,356,458
Date
25 May 2022
Ownership
Direct
AVXL transaction

Common Stock

Sale

Transaction value
$453,000
Shares
-50,000
Change %
-3.7%
Price
$9.06
Shares after
1,306,458
Date
25 May 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVXL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
+50,000
Change %
Price
$0.000000*
Shares after
0
Date
25 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$0.9200
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .